Epizyme, Inc.
EZH2 INHIBITORS FOR TREATING LYMPHOMA
Last updated:
Abstract:
The present invention relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and their use for the treatment of cancer.
Status:
Application
Type:
Utility
Filling date:
4 Mar 2020
Issue date:
15 Oct 2020